Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for …
Over the last 12 months, insiders at Bioventus Inc. have bought $901,702 and sold $389,358 worth of Bioventus Inc. stock.
On average, over the past 5 years, insiders at Bioventus Inc. have bought $2.89M and sold $595,907 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Bartholdson John A. () — $901,702.
The last purchase of 25,500 shares for transaction amount of $217,966 was made by Bartholdson John A. () on 2024‑08‑19.
2024-08-19 | 25,500 0.0418% | $8.55 | $217,966 | +43.00% | ||||
2024-08-16 | 80,000 0.1383% | $8.55 | $683,736 | +1.25% | ||||
2024-06-21 | Sale | SVP & General Counsel | 5,904 0.0079% | $5.57 | $32,885 | +95.94% | ||
2024-06-21 | Sale | SVP & CFO | 9,219 0.0123% | $5.57 | $51,350 | +95.94% | ||
2024-06-21 | Sale | SVP & Chief Compliance Officer | 2,559 0.0034% | $5.57 | $14,254 | +95.94% | ||
2024-06-17 | Sale | SVP & General Counsel | 11,308 0.0158% | $5.84 | $66,039 | +83.67% | ||
2024-06-17 | Sale | SVP & CFO | 13,753 0.0193% | $5.84 | $80,318 | +83.67% | ||
2024-06-17 | Sale | SVP & Chief Compliance Officer | 8,759 0.0123% | $5.84 | $51,153 | +83.67% | ||
2024-04-11 | Sale | SVP & General Counsel | 3,054 0.0048% | $4.75 | $14,507 | +54.89% | ||
2024-04-11 | Sale | SVP & CFO | 4,000 0.0062% | $4.75 | $19,000 | +54.89% | ||
2024-04-11 | Sale | SVP & Chief Compliance Officer | 1,325 0.0021% | $4.75 | $6,294 | +54.89% | ||
2024-03-22 | Sale | SVP & CFO | 5,541 0.0087% | $5.39 | $29,853 | +29.32% | ||
2024-03-15 | Sale | SVP & General Counsel | 3,125 0.0049% | $5.46 | $17,063 | +25.69% | ||
2024-03-15 | Sale | SVP & Chief Compliance Officer | 1,217 0.0019% | $5.46 | $6,645 | +25.69% | ||
2023-08-18 | Interim CEO | 39,885 0.0603% | $4.14 | $165,076 | +7.76% | |||
2023-08-14 | 10 percent owner | 14,985 0.0242% | $4.79 | $71,778 | -1.05% | |||
2023-08-14 | 14,985 0.0242% | $4.79 | $71,753 | -1.05% | ||||
2023-08-11 | 10 percent owner | 50,037 0.0807% | $4.56 | $228,169 | +3.76% | |||
2023-08-11 | 50,037 0.0813% | $4.60 | $229,935 | +3.76% | ||||
2023-08-10 | 10 percent owner | 111,848 0.1762% | $4.47 | $499,961 | +2.41% |
Bartholdson John A. | 6939357 10.6159% | $11.67 | 11 | 0 | +55.37% | |
D'Adamio Anthony | SVP & General Counsel | 95576 0.1462% | $11.67 | 1 | 7 | <0.0001% |
CHURCH KATRINA J | SVP & Chief Compliance Officer | 41199 0.063% | $11.67 | 1 | 10 | <0.0001% |
Juniper Investment Company, LLC | 10 percent owner | 6833857 10.4545% | $11.67 | 3 | 0 | |
HAWKINS WILLIAM A | director | 184310 0.282% | $11.67 | 2 | 0 | +54.75% |
Essex Woodlands Management Inc | $67.71M | 16.36 | 13.02M | 0% | +$0 | 19.68 | |
Juniper Investment Company | $35.54M | 8.58 | 6.83M | 0% | +$0 | 17.68 | |
Nantahala Capital Management Llc | $30.19M | 7.29 | 5.81M | -2.87% | -$891,586.79 | 1.41 | |
The Vanguard Group | $6.34M | 1.53 | 1.22M | 0% | +$0 | <0.0001 | |
Millennium Management LLC | $2.86M | 0.69 | 549,432 | +133.32% | +$1.63M | <0.01 |